Literature DB >> 31866476

Natural products targeting the PI3K-Akt-mTOR signaling pathway in cancer: A novel therapeutic strategy.

Devesh Tewari1, Pooja Patni2, Anusha Bishayee3, Archana N Sah4, Anupam Bishayee5.   

Abstract

The phosphatidylinositol 3-kinase (PI3K)-Akt and the mammalian target of rapamycin (mTOR) represent two vital intracellular signaling pathways, which are associated with various aspects of cellular functions. These functions play vital roles in quiescence, survival, and growth in normal physiological circumstances as well as in various pathological disorders, including cancer. These two pathways are so intimately connected to each other that in some instances these are considered as one unique pathway crucial for cell cycle regulation. The purpose of this review is to emphasize the role of PI3K-Akt-mTOR signaling pathway in different cancer conditions and the importance of natural products targeting the PI3K-Akt-mTOR signaling pathway. This review also aims to draw the attention of scientists and researchers to the assorted beneficial effects of the numerous classes of natural products for the development of new and safe drugs for possible cancer therapy. We also summarize and critically analyze various preclinical and clinical studies on bioactive compounds and constituents, which are derived from natural products, to target the PI3K-Akt-mTOR signaling pathway for cancer prevention and intervention.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Breast cancer; Lymphoma; Natural compounds; PI3K-Akt; Phytochemicals; Polyphenols; Prostate cancer; Sarcoma; mTOR

Mesh:

Substances:

Year:  2019        PMID: 31866476     DOI: 10.1016/j.semcancer.2019.12.008

Source DB:  PubMed          Journal:  Semin Cancer Biol        ISSN: 1044-579X            Impact factor:   15.707


  42 in total

1.  Modulation of TLR/NF-κB/NLRP Signaling by Bioactive Phytocompounds: A Promising Strategy to Augment Cancer Chemotherapy and Immunotherapy.

Authors:  Sajad Fakhri; Seyed Zachariah Moradi; Akram Yarmohammadi; Fatemeh Narimani; Carly E Wallace; Anupam Bishayee
Journal:  Front Oncol       Date:  2022-03-01       Impact factor: 6.244

Review 2.  Phytochemicals for the Prevention and Treatment of Renal Cell Carcinoma: Preclinical and Clinical Evidence and Molecular Mechanisms.

Authors:  Essa M Bajalia; Farah B Azzouz; Danielle A Chism; Derrek M Giansiracusa; Carina G Wong; Kristina N Plaskett; Anupam Bishayee
Journal:  Cancers (Basel)       Date:  2022-07-04       Impact factor: 6.575

3.  Clinical review considerations of class I PI3K inhibitors in hematolymphatic malignancies by Center for Drug Evaluation.

Authors:  Limin Zou; Yueli Qi; Ling Tang; Yu Du; Meiyi Xiang; Xiaoming Chen; Jun Ma; Zhimin Yang
Journal:  Chin J Cancer Res       Date:  2022-08-30       Impact factor: 4.026

4.  Comparison of dual mTORC1/2 inhibitor AZD8055 and mTORC1 inhibitor rapamycin on the metabolism of breast cancer cells using proton nuclear magnetic resonance spectroscopy metabolomics.

Authors:  Zhitao Ni; Shaolin Xu; Zheng Yu; Zhongjiang Ye; Rongqi Li; Chuang Chen; Jianhui Yang; Huamin Liu; Ziye Zhou; Xiuhua Zhang
Journal:  Invest New Drugs       Date:  2022-09-05       Impact factor: 3.651

Review 5.  Pharmacological Properties of 4', 5, 7-Trihydroxyflavone (Apigenin) and Its Impact on Cell Signaling Pathways.

Authors:  Rameesha Abid; Shakira Ghazanfar; Arshad Farid; Samra Muhammad Sulaman; Maryam Idrees; Radwa Abdallnasser Amen; Muhammad Muzammal; Muhammad Khurram Shahzad; Mohamed Omar Mohamed; Alaa Ashraf Khaled; Waqas Safir; Ifra Ghori; Abdelbaset Mohamed Elasbali; Bandar Alharbi
Journal:  Molecules       Date:  2022-07-04       Impact factor: 4.927

6.  Berbamine Inhibits Cell Proliferation and Migration and Induces Cell Death of Lung Cancer Cells via Regulating c-Maf, PI3K/Akt, and MDM2-P53 Pathways.

Authors:  Lili Liu; Zhiying Xu; Binbin Yu; Li Tao; Ying Cao
Journal:  Evid Based Complement Alternat Med       Date:  2021-07-08       Impact factor: 2.629

Review 7.  Epigenetic Regulation of Hepatocellular Carcinoma Progression through the mTOR Signaling Pathway.

Authors:  Mengnan Guo; Ning Li; Jianxia Zheng; Wei Wang; Yan Wu; Xu Han; Jiapei Guo; Weixi Chen; Zekun Bai; Wen Bai; Jinghua Wu
Journal:  Can J Gastroenterol Hepatol       Date:  2021-05-25

8.  Iridin Induces G2/M Phase Cell Cycle Arrest and Extrinsic Apoptotic Cell Death through PI3K/AKT Signaling Pathway in AGS Gastric Cancer Cells.

Authors:  Pritam-Bhagwan Bhosale; Preethi Vetrivel; Sang-Eun Ha; Hun-Hwan Kim; Jeong-Doo Heo; Chung-Kil Won; Seong-Min Kim; Gon-Sup Kim
Journal:  Molecules       Date:  2021-05-10       Impact factor: 4.411

9.  Ipriflavone Suppresses Growth of Esophageal Squamous Cell Carcinoma Through Inhibiting mTOR In Vitro and In Vivo.

Authors:  Xiaodan Shi; Yuanyuan Zhang; Xiaomeng Xie; Mengjun Pang; Kyle Laster; Jian Li; Xinli Ma; Kangdong Liu; Zigang Dong; Dong Joon Kim
Journal:  Front Oncol       Date:  2021-06-10       Impact factor: 6.244

10.  Andrographolide Suppresses the Growth and Metastasis of Luminal-Like Breast Cancer by Inhibiting the NF-κB/miR-21-5p/PDCD4 Signaling Pathway.

Authors:  Junchen Li; Lixun Huang; Zinan He; Minggui Chen; Yi Ding; Yuying Yao; Youfa Duan; Li Zixuan; Cuiling Qi; Lingyun Zheng; Jiangchao Li; Rongxin Zhang; Xiaoming Li; Jianwei Dai; Lijing Wang; Qian-Qian Zhang
Journal:  Front Cell Dev Biol       Date:  2021-06-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.